A Long-Term Safety And Tolerability Study Of Bapineuzumab In Alzheimer Disease Patients

Clinical trial NCT00996918 · TERMINATED

Trial details

NCT number: NCT00996918
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Alzheimer Disease

Start date: 2009-12-01
Primary completion: 2012-11-01
Enrollment: 198

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.